portfolio-icon
portfolio-icon
portfolio-icon

SYFE SELECT THEMES

Healthcare Innovation

Invest in companies that are the forefront of healthcare innovation.
illustration
illustration
illustration
portfolio-icon
portfolio-icon
portfolio-icon

SYFE SELECT THEMES

Healthcare Innovation

Invest in companies that are the forefront of healthcare innovation.
illustration
illustration
illustration
portfolio-icon
portfolio-icon
portfolio-icon

SYFE SELECT THEMES

Healthcare Innovation

Invest in companies that are the forefront of healthcare innovation.
illustration
illustration
illustration
portfolio-icon
portfolio-icon
portfolio-icon

SYFE SELECT THEMES

Healthcare Innovation

Invest in companies that are the forefront of healthcare innovation.
illustration
illustration
illustration
Syfe's Healthcare Innovation portfolio invests across the full spectrum of healthcare stocks. Capturing evolving trends in the healthcare sector, the portfolio focuses on genomics and biotechnology, pharmaceuticals, healthcare services such as insurance and specialized treatment, and medical devices.
Syfe's Healthcare Innovation portfolio invests across the full spectrum of healthcare stocks. Capturing evolving trends in the healthcare sector, the portfolio focuses on genomics and biotechnology, pharmaceuticals, healthcare services such as insurance and specialized treatment, and medical devices.
Syfe's Healthcare Innovation portfolio invests across the full spectrum of healthcare stocks. Capturing evolving trends in the healthcare sector, the portfolio focuses on genomics and biotechnology, pharmaceuticals, healthcare services such as insurance and specialized treatment, and medical devices.
Theme illustration
Theme illustration

Over 100,000+ investors trust the Syfe brand
to grow their wealth

Platform partners
platform-partners
platform-partners
platform-partners
abf-award

Invest in the fastest growing

Healthcare Innovation sectors

Biotherapeutics & Biomaterials
Healthcare Development
Medical Devices
Genomic Revolution
Sequencing & Diagnostics
Biotherapeutics & Biomaterials
Healthcare Development
Medical Devices
Genomic Revolution
Sequencing & Diagnostics
Biotherapeutics & Biomaterials
Healthcare Development
Medical Devices
Genomic Revolution
Sequencing & Diagnostics

Our Selection Methodology

Investments focused on healthcare advancements like genomics, biotechnology, and pharmaceuticals
Primary exposure to large-cap healthcare stocks in developed markets
All new healthcare themes are actively monitored for possible inclusion
We use a proprietary methodolgy to optimise portfolio allocations.

Annualised Past Returns
Source: Syfe internal backtested data provided by underlying ETF participants and/or supported by the historical securities data. Annualised past return is the geometric average calculated on daily NAVs with gross income reinvested over the backtested period. The backtested period is as of 28th Feb 2023 14:30 HKT. The returns are calculated before management fees. Different customer tiers will have different fee structures and performance may not be the same.

Past returns are not a guarantee for future performance.
Source: Syfe internal backtested data provided by underlying ETF participants and/or supported by the historical securities data. Annualised past return is the geometric average calculated on daily NAVs with gross income reinvested over the backtested period. The backtested period is as of 28th Feb 2023 14:30 HKT. The returns are calculated before management fees. Different customer tiers will have different fee structures and performance may not be the same.

Past returns are not a guarantee for future performance.

More
YTD

-2.14%

1 Year

-8.59%

3 Years

9.6%

5 Years

9.68%

Overall Risk Rating

1005
Very high
Learn more

Invest your way

Start investing in the fastest growing healthcare, biotech and gene editing companies today.

Join over 100,000+ investors on Syfe now

How thematic portfolio works?

  • Choose from five thematic portfolios

  • Use it to complement or diversify your core investments

Join over 100,000+ investors on Syfe now

How thematic portfolio works?

  • Choose from five thematic portfolios

  • Use it to complement or diversify your core investments

Join over 100,000+ investors on Syfe now

How thematic portfolio works?
  • Choose from five thematic portfolios

  • Use it to complement or diversify your core investments

Invest in global megatrends

  • Invest in ESG, innovation, healthcare, China growth, and high-yield assets
  • Automatic rebalancing and dividend reinvesting
  • No brokerage fees, no minimum balance*, no lock-ins
*As per SFC regulations, the first transfer has to be at least HK$10,000 from a local bank account.Learn more

Simple, all-inclusive fee from 0.35%

Simple, all-inclusive fee from 0.35%

Simple, all-inclusive fee from 0.35%

In July 2021, Syfe closed Series B funding round led by Valar Ventures, bringing total funding round to date to over US$52 million
Advisory Image
Advisory Image
Advisory Image

Talk to our Wealth Experts

General Enquiries

Get help in understanding Syfe’s portfolios, fees and platform features

Personalised consultation for Black tier and above

Get a personalised consultation based on your goals if you are planning to invest more than HK$200,000.

Private Wealth

Bespoke solutions for high and ultra-high net worth individuals, families and institutions
Explore Private Wealth

Frequently asked questions

What are Syfe Select Themes?

Icon
Syfe Select Themes is a way to apply thematic investing to your portfolio. Many investors want their portfolios to reflect their values and investment preferences. With thematic portfolios, you can do just that.

Syfe Select Themes offers five different portfolio themes: ESG & Clean Energy, Disruptive Technology, Healthcare Innovation, China Growth, and Global Income.

Can I invest in multiple theme portfolios?

Icon
Of course! You may invest in multiple Syfe Select Themes portfolios depending on your investment goals and risk appetite.

How safe are Syfe Select Themes?

Icon
All forms of investments carry a certain degree of risk. Clients should consider their personal risk appetite and evaluate it against the risk rating of each Syfe Select Themes portfolio, which are in turn determined using weighted average risk scores of the individual ETFs within the portfolio. In general, thematic portfolios should be used to complement your core investment holdings and should make up less than 30% of your overall portfolio allocation.

Will there be dividends for Syfe Select Theme portfolios?

Icon
Some of the underlying ETFs in Syfe Select Theme portfolios distribute dividends. These will be credited to your portfolio automatically and reinvested for you at no charge.
As featured in
Pronounced as
Sounds like life
Why the name Syfe?
In Japanese, the word Saifu means wallet and to be closely associated with our most important attribute - which is the word safe
Sign up for News & Updates

Connect
[email protected]
+852-2833-1017
305-306, Spaces 8 Queen’s Road East, Wan Chai, Hong Kong
Download App now
IconIconIcon
The information contained herein is for general information and reference purposes only. Information on this website is not and should not be construed as an offer to sell, or a solicitation of an offer to buy any security, investment product or service, nor a distribution of information for any such purpose. It is not intended to form the basis of any investment decision.
Investors should not make any investment decision based solely on the information and services provided herein. Before making any investment decision, investors browsing this website should consider his/her own circumstances including but not limited to his/her financial situation, investment experience and investment objectives, and should understand the nature, terms and risks of the relevant investment funds in detail.
Unless otherwise specified, all historical figures shown are for illustration purposes only and not necessarily indicative of future performance. All forms of investment carry risks, including fluctuation of prices of fund units and the possibility of loss of the capital invested. Please ensure that you fully understand the risks and costs involved by reading the Risk Disclosure Statement.
The fund(s) mentioned above may not be authorised by the Securities and Futures Commission ("SFC") in Hong Kong. Please seek professional advice from an independent financial consultant where necessary. The webpage(s) have not been reviewed by the SFC. Syfe Hong Kong Limited (“Syfe”) is a Hong Kong Corporation licensed by the SFC (CE No. BRQ741) under Types 1 (Dealing in Securities), 4 (Advising on Securities), and 9 (Asset Management) for conducting relevant investment activities.
Every reasonable care has been taken by Syfe to ensure that the information included on this website is correct, up-to-date, complete, fit for its intended purpose and in line with relevant legislation and regulations. However, errors or omissions may occur due to circumstances out of Syfe’s control and information or forecast, being current only as at the date it is first posted, showing prevailing market conditions and certain assumptions (which may not be proven valid) posted on this website is and may no longer be true or complete when viewed by you. No warranty will be given or representation made, regarding the accuracy, validity or completeness of the information on this website and no liability is accepted by such persons for the accuracy or completeness of such information.
supportsupport-loader